A detailed history of Smartleaf Asset Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 383 shares of MYGN stock, worth $5,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
383
Previous 186 105.91%
Holding current value
$5,932
Previous $4.52 Million 124.15%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.97 - $28.6 $4,722 - $5,634
197 Added 105.91%
383 $10.1 Million
Q2 2024

Aug 13, 2024

BUY
$17.98 - $25.47 $215 - $305
12 Added 6.9%
186 $4.52 Million
Q1 2024

Oct 07, 2024

SELL
$17.59 - $23.59 $211 - $283
-12 Reduced 6.45%
174 $3.72 Million
Q1 2024

May 02, 2024

BUY
$17.59 - $23.59 $3,060 - $4,104
174 New
174 $3.43 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.